Kyle Anderson

Kyle Anderson is an experienced biotechnology professional specializing in biologics manufacturing, currently serving as a CMC Asset Lead. They have held various roles in notable organizations such as Biogen and Resilience, where they successfully managed cross-functional teams, led tech transfer initiatives, and contributed to regulatory filings. Kyle earned a Ph.D. in Microbiology from Cornell University and a BS in Biotechnology from Rochester Institute of Technology. Throughout their career, Kyle has demonstrated a commitment to improving manufacturing processes and mentoring team members.